speb/financial-data huggingface dataset:
Financial ratios for UT8.DE — annual report dated 2022-12-31
Total revenue: 31877000000
Gross profit: 12218000000
Operating income: -1832000000
Net income: -9138000000
Capital expenditures: 252000000
Operating cash flow: 642000000
Depreciation & amortization: 947000000
Net tangible assets: -2797000000
Owner earnings: -8443000000
Buffett classification: The Gruesome
Stock price: 24.617021276595747
Shares outstanding: 2035599013
Book value: 8504000000
P/B ratio: 5.892566346853045
Market cap (USD): 50110384213.6383
Debt to equity: 1.3098541862652868
Current ratio: 1.0447305997966791
Quick ratio: 1.0447305997966791
Interest coverage ratio: -3.2424778761061948
COGS to revenue (%): 61.671424538068194
R&D to revenue (%): 8.777488471311603
SG&A to revenue (%): 24.757662264328513
Free cash flow (dilution-adjusted): -1403000000
Buyback yield (%): 0
Retained earnings: -32767000000
Receivables turnover: 9.136428776153625
Capitalized R&D asset: 2798000000
ROCI (R&D-adjusted, %): 0.1279394078964204
FCF margin (%): -4.401292467923581
Rule of 40 score: -4.401292467923581
Financial ratios for UT8.DE — annual report dated 2023-12-31
Total revenue: 37281000000
Gross profit: 14824000000
Operating income: 1110000000
Net income: 2156000000
Capital expenditures: 223000000
Operating cash flow: 3585000000
Depreciation & amortization: 823000000
Net tangible assets: 1673000000
Owner earnings: 2756000000
Return on net tangible assets (%): 164.73401075911536
Capex to operating income (%): 20.09009009009009
Buffett classification: The Great
Stock price: 62.666666666666664
P/E ratio: 59.167070878787875
Shares outstanding: 2035599013
Book value: 12682000000
P/B ratio: 10.058681975608474
Market cap (USD): 127564204814.66666
Debt to equity: 0.8850339063239236
Current ratio: 1.194943939073408
Quick ratio: 1.194943939073408
Effective tax rate (%): 9.17707884532529
Interest coverage ratio: 1.7535545023696681
COGS to revenue (%): 60.237118103055174
R&D to revenue (%): 8.486896810707867
SG&A to revenue (%): 18.87824897400821
Free cash flow (dilution-adjusted): 1427000000
Buyback yield (%): 0
Retained earnings: -30594000000
Receivables turnover: 9.046590633341422
Capitalized R&D asset: 5038660000
ROCI (R&D-adjusted, %): 6.669844079268862
Rosenberg metric: 0.9313795568263045
FCF margin (%): 3.827687025562619
Revenue growth (%): 16.952661793769803
Rule of 40 score: 20.78034881933242
Financial ratios for UT8.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.93333333333332
Shares outstanding: 2035599013
Market cap (USD): 152534219374.1333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UT8.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.520833333333336
Shares outstanding: 2035599013
Market cap (USD): 123196148599.27084
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UT8.DE — annual report dated 2024-12-31
Total revenue: 43978000000
Gross profit: 17327000000
Operating income: 2799000000
Net income: 9856000000
Capital expenditures: 242000000
Operating cash flow: 7137000000
Depreciation & amortization: 737000000
Net tangible assets: 12367000000
Owner earnings: 10351000000
Return on net tangible assets (%): 83.69855259966039
Capex to operating income (%): 8.645944980350125
Buffett classification: The Great
Stock price: 60.520833333333336
P/E ratio: 12.499609232880564
Shares outstanding: 2035599013
Book value: 22476000000
P/B ratio: 5.481231028620344
Market cap (USD): 123196148599.27084
Debt to equity: 0.49501690692294004
Current ratio: 1.06700941094458
Quick ratio: 1.06700941094458
Effective tax rate (%): -139.5878787878788
Interest coverage ratio: 5.351816443594647
COGS to revenue (%): 60.600754922916
R&D to revenue (%): 7.069443812815498
SG&A to revenue (%): 18.13634089772159
Free cash flow (dilution-adjusted): 5099000000
Buyback yield (%): 1.0162655360862556
Retained earnings: -20726000000
Receivables turnover: 13.194719471947195
Capitalized R&D asset: 6152220000
ROCI (R&D-adjusted, %): 6.281183612215563
Rosenberg metric: 0.7910872313527181
FCF margin (%): 11.594433580426578
Revenue growth (%): 17.963573938467317
Rule of 40 score: 29.558007518893895
Financial ratios for UT8.DE — quarterly report dated 2025-03-31
Total revenue: 11533000000
Gross profit: 4596000000
Operating income: 1228000000
Net income: 1776000000
Capital expenditures: 74000000
Operating cash flow: 2324000000
Depreciation & amortization: 178000000
Net tangible assets: 12841000000
Owner earnings: 1880000000
Return on net tangible assets (%): 14.640604314305738
Capex to operating income (%): 6.026058631921824
Buffett classification: The Great
Stock price: 72.28260869565217
P/E ratio: 20.712050523357934
Shares outstanding: 2035599013
Book value: 22905000000
P/B ratio: 6.42385535550905
Market cap (USD): 147138406917.93478
Debt to equity: 0.4856581532416503
Current ratio: 1.019565755799554
Quick ratio: 1.019565755799554
Effective tax rate (%): -29.025270758122744
Interest coverage ratio: 11.695238095238095
COGS to revenue (%): 60.14913725830227
R&D to revenue (%): 7.066678227694442
SG&A to revenue (%): 14.861701205237146
Free cash flow (dilution-adjusted): 1815000000
Buyback yield (%): 1.2131434867278186
Retained earnings: -18946000000
Receivables turnover: 2.8825293676580857
Capitalized R&D asset: 815000000
ROCI (R&D-adjusted, %): 4.265806120155411
FCF margin (%): 15.737449059221365
Rule of 40 score: 15.737449059221365
Financial ratios for UT8.DE — quarterly report dated 2025-06-30
Total revenue: 12651000000
Gross profit: 5040000000
Operating income: 1450000000
Net income: 1355000000
Capital expenditures: 89000000
Operating cash flow: 2564000000
Depreciation & amortization: 181000000
Net tangible assets: 12504000000
Owner earnings: 1447000000
Return on net tangible assets (%): 11.5722968650032
Capex to operating income (%): 6.137931034482759
Buffett classification: The Great
Stock price: 92.63529411764705
P/E ratio: 60.226225894234126
Shares outstanding: 2035599013
Book value: 23630000000
P/B ratio: 7.980038648956709
Market cap (USD): 188568313274.84705
Debt to equity: 0.5223021582733813
Current ratio: 1.1120132429449787
Quick ratio: 1.1120132429449787
Effective tax rate (%): 9.441489361702128
Interest coverage ratio: 13.425925925925926
COGS to revenue (%): 60.161252074934794
R&D to revenue (%): 6.639791320844202
SG&A to revenue (%): 14.852580823650305
Free cash flow (dilution-adjusted): 2000000000
Buyback yield (%): 0.7228149715765684
Retained earnings: -17592000000
Receivables turnover: 2.8713118474807082
Capitalized R&D asset: 1386050000
ROCI (R&D-adjusted, %): 3.8904511617827144
Rosenberg metric: 0.5447852760736196
FCF margin (%): 15.809026954390957
Revenue growth (%): 9.693921789647101
Rule of 40 score: 25.502948744038058
Financial ratios for UT8.DE — quarterly report dated 2025-09-30
Total revenue: 13467000000
Gross profit: 5358000000
Operating income: 1113000000
Net income: 6652000000
Capital expenditures: 98000000
Operating cash flow: 2328000000
Depreciation & amortization: 195000000
Net tangible assets: 18113000000
Owner earnings: 6749000000
Return on net tangible assets (%): 37.2605311102523
Capex to operating income (%): 8.80503144654088
Buffett classification: The Great
Stock price: 97.6
P/E ratio: 20.3081328497189
Shares outstanding: 2035599013
Book value: 29155000000
P/B ratio: 6.814421665882353
Market cap (USD): 198674463668.8
Debt to equity: 0.4575544503515692
Current ratio: 1.1537992531057084
Quick ratio: 1.1537992531057084
Effective tax rate (%): -154.42748091603053
Interest coverage ratio: 9.9375
COGS to revenue (%): 60.21385609267097
R&D to revenue (%): 6.400831662582609
SG&A to revenue (%): 18.26687458231232
Free cash flow (dilution-adjusted): 1765000000
Buyback yield (%): 0.736380495501874
Retained earnings: -10935000000
Receivables turnover: 3.5693082427776304
Capitalized R&D asset: 1693750000
ROCI (R&D-adjusted, %): 2.1881184781404843
Rosenberg metric: 0.37857142857142856
FCF margin (%): 13.106111234870424
Revenue growth (%): 6.450082997391511
Rule of 40 score: 19.556194232261934
Financial ratios for UT8.DE — quarterly report dated 2025-12-31
Total revenue: 14366000000
Gross profit: 5685000000
Operating income: 1774000000
Net income: 317000000
Capital expenditures: 75000000
Operating cash flow: 2883000000
Depreciation & amortization: 193000000
Net tangible assets: 17062000000
Owner earnings: 435000000
Return on net tangible assets (%): 2.5495252608135037
Capex to operating income (%): 4.227733934611049
Buffett classification: The Great
Stock price: 81.94117647058825
P/E ratio: 16.514789895800817
Shares outstanding: 2035599013
Book value: 28083000000
P/B ratio: 5.939514223821822
Market cap (USD): 166799377947.58826
Debt to equity: 0.4301534736317345
Current ratio: 1.1357954545454545
Quick ratio: 1.1357954545454545
Effective tax rate (%): -13.745704467353953
Interest coverage ratio: 15.42608695652174
COGS to revenue (%): 60.42739802311012
R&D to revenue (%): 6.160378671864124
SG&A to revenue (%): 14.520395377975776
Free cash flow (dilution-adjusted): 2357000000
Buyback yield (%): 1.1462872485056803
Retained earnings: -10628000000
Receivables turnover: 3.75385419388555
Capitalized R&D asset: 1739740000
ROCI (R&D-adjusted, %): 3.5076252127839984
Rosenberg metric: 0.37935034802784223
FCF margin (%): 16.406793818738688
Revenue growth (%): 6.675577337194624
Rule of 40 score: 23.082371155933313
Financial ratios for UT8.DE — annual report dated 2025-12-31
Total revenue: 52017000000
Gross profit: 20679000000
Operating income: 5565000000
Net income: 10093000000
Capital expenditures: 336000000
Operating cash flow: 10099000000
Depreciation & amortization: 747000000
Net tangible assets: 17062000000
Owner earnings: 10504000000
Return on net tangible assets (%): 61.56370882663228
Capex to operating income (%): 6.037735849056604
Buffett classification: The Great
Stock price: 81.94117647058825
P/E ratio: 16.52624372808761
Shares outstanding: 2035599013
Book value: 28083000000
P/B ratio: 5.939514223821822
Market cap (USD): 166799377947.58826
Debt to equity: 0.4301534736317345
Current ratio: 1.1357954545454545
Quick ratio: 1.1357954545454545
Effective tax rate (%): -74.93103448275862
Interest coverage ratio: 12.647727272727273
COGS to revenue (%): 60.245688909395
R&D to revenue (%): 6.540169559951554
SG&A to revenue (%): 15.646807774381452
Free cash flow (dilution-adjusted): 7937000000
Buyback yield (%): 3.9106860470724647
Retained earnings: -10628000000
Receivables turnover: 13.592108701332636
Capitalized R&D asset: 6529150000
ROCI (R&D-adjusted, %): 10.251530275668328
Rosenberg metric: 1.0781601801222258
FCF margin (%): 15.25847319145664
Revenue growth (%): 18.279594342625856
Rule of 40 score: 33.538067534082494
Financial ratios for VIKASLIFE.NS — annual report dated 2022-03-31
Total revenue: 39683739.94461295
Gross profit: 1339733.614664381
Operating income: -274205.4595806409
Net income: 3817328.234208097
Capital expenditures: 14519.319530528815
Operating cash flow: -1962745.6151918767
Depreciation & amortization: 199406.56732164053
Net tangible assets: 24113424.765923776
Owner earnings: 4002215.4819992087
Return on net tangible assets (%): 16.59745772676387
Buffett classification: The Gruesome
Stock price: 0.06989318211789529
P/E ratio: 34.01289043348488
Shares outstanding: 1857668560
Book value: 26329711.196096532
P/B ratio: 4.9312491888637675
Market cap (USD): 129838366.97876829
Debt to equity: 0.11558303140066373
Current ratio: 1.1651107045984987
Quick ratio: 0.8928221214223864
Effective tax rate (%): 25.93979864655691
Interest coverage ratio: -1.5100217864923744
COGS to revenue (%): 96.62397340438612
SG&A to revenue (%): 1.9866290843667689
Free cash flow (dilution-adjusted): -3706026.638533562
Buyback yield (%): 0
Retained earnings: 2672055.9145456944
Inventory turnover: 10.205956580494567
Receivables turnover: 7.038859455223793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9619753040726533
FCF margin (%): -9.338904658951263
Rule of 40 score: -9.338904658951263
Financial ratios for VIKASLIFE.NS — annual report dated 2023-03-31
Total revenue: 57983934.226552986
Gross profit: 2962228.989037759
Operating income: 1066248.4774665043
Net income: -1863471.3763702803
Capital expenditures: 1522.5334957369064
Operating cash flow: -13666419.001218028
Depreciation & amortization: 366552.98416565167
Net tangible assets: 38014202.192448236
Owner earnings: -1498440.9257003656
Return on net tangible assets (%): -3.941792380948719
Capex to operating income (%): 0.14279349775528624
Buffett classification: The Great
Stock price: 0.04080389768574909
Shares outstanding: 1857668560
Book value: 40634177.8319123
P/B ratio: 1.8654276252328343
Market cap (USD): 75800117.85627285
Debt to equity: 0.09114717754384956
Current ratio: 2.1348734236144877
Quick ratio: 2.0170257629522483
Interest coverage ratio: 3.803397636426834
COGS to revenue (%): 94.89129354785787
SG&A to revenue (%): 0.7383707654751694
Free cash flow (dilution-adjusted): -15833447.01583435
Buyback yield (%): 0
Retained earnings: 597247.2594397077
Inventory turnover: 36.05058098703952
Receivables turnover: 2.8100171712479285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5120575260283875
FCF margin (%): -27.306610403444527
Revenue growth (%): 46.11509476546773
Rule of 40 score: 18.808484362023204
Financial ratios for VIKASLIFE.NS — annual report dated 2024-03-31
Total revenue: 53453099.89207339
Gross profit: 3175512.65139705
Operating income: 81256.74541311908
Net income: 1682348.0033577168
Capital expenditures: 1131574.5293200624
Operating cash flow: -5006415.637366591
Depreciation & amortization: 437222.6885717712
Net tangible assets: 54975692.52908023
Owner earnings: 987996.1626094256
Return on net tangible assets (%): 1.7971509173564482
Capex to operating income (%): 1392.5914994096813
Buffett classification: The Gruesome
Stock price: 0.05818138195777351
P/E ratio: 64.24456998468332
Shares outstanding: 1857668560
Book value: 57372910.42091378
P/B ratio: 1.8838459343855907
Market cap (USD): 108081724.0403071
Debt to equity: 0.07208871801613895
Current ratio: 4.474821167213801
Quick ratio: 4.302378073659268
Effective tax rate (%): 21.24380235437362
Interest coverage ratio: 0.25078648358562494
COGS to revenue (%): 94.05925445332694
SG&A to revenue (%): 1.2385769993363924
Free cash flow (dilution-adjusted): -6921717.232282048
Buyback yield (%): 0
Retained earnings: 2313526.8017747933
Inventory turnover: 45.5049926196058
Receivables turnover: 3.053299549757823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.13517662433885444
FCF margin (%): -12.949140922149729
Revenue growth (%): -7.813947768319515
Rule of 40 score: -20.763088690469246
Financial ratios for VIKASLIFE.NS — quarterly report dated 2024-09-30
Total revenue: 16110403.726708075
Gross profit: 589620.1624462494
Operating income: -176994.74438604873
Net income: 285439.56043956045
Capital expenditures: 0
Depreciation & amortization: 220473.00525561394
Net tangible assets: 62786884.85427616
Owner earnings: 505912.5656951744
Return on net tangible assets (%): 0.8057615326343408
Buffett classification: The Gruesome
Stock price: 0.05339225991399904
P/E ratio: 86.87051160396702
Shares outstanding: 1857668560
Book value: 65081796.464405164
P/B ratio: 1.524007141441326
Market cap (USD): 99185122.58958432
Debt to equity: 0.11279623862653634
Current ratio: 1.1885461683667042
Quick ratio: 1.1375628097021526
Interest coverage ratio: -1.4351573849878934
COGS to revenue (%): 96.34012795428107
Buyback yield (%): 0
Inventory turnover: 19.69324967415356
Receivables turnover: 1.4289469279129048
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.24785489599561628
Rule of 40 score: 0
Financial ratios for VIKASLIFE.NS — quarterly report dated 2024-12-31
Total revenue: 13736927.380813614
Gross profit: 271033.9200373004
Operating income: -418615.22321948945
Net income: -793985.3129735399
Capital expenditures: 0
Depreciation & amortization: 170229.63049306444
Owner earnings: -623755.6824804755
Buffett classification: The Gruesome
Stock price: 0.04930644597272409
Shares outstanding: 1857668560
Market cap (USD): 91595034.48886816
Interest coverage ratio: -2.521272114574558
COGS to revenue (%): 98.02696838584258
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -14.732569004212326
Rule of 40 score: -14.732569004212326
Financial ratios for VIKASLIFE.NS — annual report dated 2025-03-31
Total revenue: 56116717.32522796
Gross profit: 1757248.071077858
Operating income: -3321440.2618657937
Net income: -1240811.3163432311
Capital expenditures: 1397334.5803133035
Operating cash flow: -25976525.602057517
Depreciation & amortization: 787397.7086743043
Net tangible assets: 60142202.478372686
Owner earnings: -1850748.1879822304
Return on net tangible assets (%): -3.0772870159648127
Buffett classification: The Gruesome
Stock price: 0.03127552806628545
Shares outstanding: 1857668560
Book value: 62334054.24362871
P/B ratio: 0.9320678061314223
Market cap (USD): 58099565.18613608
Debt to equity: 0.1438469783226167
Current ratio: 1.768595409397995
Quick ratio: 1.7371888539213984
Interest coverage ratio: -6.311304618255327
COGS to revenue (%): 96.8685836327638
SG&A to revenue (%): 1.658505936389635
Free cash flow (dilution-adjusted): -27439735.79611877
Buyback yield (%): 0
Retained earnings: 967711.0123918634
Inventory turnover: 96.97007424090758
Receivables turnover: 3.7497707278434045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.927620436766198
FCF margin (%): -48.897613944682575
Revenue growth (%): 4.98309254006344
Rule of 40 score: -43.91452140461914
Financial ratios for VIKASLIFE.NS — quarterly report dated 2025-03-31
Total revenue: 15806008.884732287
Gross profit: 545195.2303016132
Operating income: -2537830.2548515312
Net income: -329915.828851999
Capital expenditures: 0
Depreciation & amortization: 247837.26911386484
Net tangible assets: 60142202.478372686
Owner earnings: -82078.55973813418
Return on net tangible assets (%): -0.13647415019037568
Buffett classification: The Gruesome
Stock price: 0.03127552806628545
Shares outstanding: 1857668560
Book value: 62334054.24362871
P/B ratio: 0.9320678061314223
Market cap (USD): 58099565.18613608
Debt to equity: 0.1438469783226167
Current ratio: 1.768595409397995
Quick ratio: 1.7371888539213984
Interest coverage ratio: -14.894408233276158
COGS to revenue (%): 96.55070907350786
Buyback yield (%): 0
Retained earnings: 967711.0123918634
Inventory turnover: 27.223264931598266
Receivables turnover: 1.0561720689488163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.765072752452615
Revenue growth (%): 15.062185644284348
Rule of 40 score: 15.062185644284348
Financial ratios for VIKASLIFE.NS — quarterly report dated 2025-06-30
Total revenue: 10810156.798502224
Gross profit: 344675.87175286683
Operating income: -519424.2920664639
Net income: -462520.47741633514
Capital expenditures: 0
Depreciation & amortization: 172923.00491457994
Owner earnings: -289597.4725017552
Buffett classification: The Gruesome
Stock price: 0.03042358998361807
Shares outstanding: 1857668560
Market cap (USD): 56516946.5948982
Interest coverage ratio: -3.843290043290043
COGS to revenue (%): 96.81155529769354
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -31.607296457082057
Rule of 40 score: -31.607296457082057
Financial ratios for VIKASLIFE.NS — quarterly report dated 2025-09-30
Total revenue: 15933100.338218715
Gross profit: 303449.8308906426
Operating income: -578590.7553551296
Net income: -13410620.067643743
Capital expenditures: 0
Depreciation & amortization: 169323.56257046224
Net tangible assets: 60392750.84554678
Owner earnings: -13241296.505073281
Return on net tangible assets (%): -21.92530778890603
Buffett classification: The Gruesome
Stock price: 0.024577226606538896
Shares outstanding: 1857668560
Book value: 62453337.09131905
P/B ratio: 0.7310472632103591
Market cap (USD): 45656341.1589628
Debt to equity: 0.1750819687519575
Current ratio: 1.6611260183071097
Quick ratio: 1.5904684385152894
Interest coverage ratio: -2.795718254616767
COGS to revenue (%): 98.09547530330455
Buyback yield (%): 0
Inventory turnover: 13.534212607265237
Receivables turnover: 1.2860113216852769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8753167034359605
Revenue growth (%): 47.39009466010973
Rule of 40 score: 47.39009466010973
Financial ratios for VIT.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
Shares outstanding: 662741837
Market cap (USD): 49830213.30827067
Buyback yield (%): 0.2593604181955394
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIT.AX — annual report dated 2022-06-30
Total revenue: 46201194.48275862
Gross profit: 17536019.310344826
Operating income: 6371542.75862069
Net income: 4171402.7586206896
Capital expenditures: 251890.3448275862
Depreciation & amortization: 471249.6551724138
Net tangible assets: 13064962.75862069
Owner earnings: 4390762.068965518
Return on net tangible assets (%): 33.607153346597556
Capex to operating income (%): 3.9533650541194105
Buffett classification: The Great
Stock price: 0.15862068965517243
P/E ratio: 25.201250833673086
Shares outstanding: 662741837
Book value: 17982612.413793106
P/B ratio: 5.845900741743327
Market cap (USD): 105124567.24827588
Debt to equity: 0.19404169268797122
Current ratio: 2.266606918363787
Quick ratio: 1.8533353348028854
Effective tax rate (%): 38.29953675207605
Interest coverage ratio: 20.928635828198622
COGS to revenue (%): 62.04422957746487
SG&A to revenue (%): 21.881960000675907
Free cash flow (dilution-adjusted): 9053677.241379311
Buyback yield (%): 0.7777538269400064
Retained earnings: 4465451.724137931
Inventory turnover: 8.263399730255875
Receivables turnover: 11.632425550667982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.098205888665458
FCF margin (%): 19.596197333724707
Rule of 40 score: 19.596197333724707
Financial ratios for VIT.AX — annual report dated 2023-06-30
Total revenue: 77711015.23178808
Gross profit: 26848486.09271523
Operating income: 13154823.841059603
Net income: 9145290.72847682
Capital expenditures: 610194.701986755
Depreciation & amortization: 654540.3973509934
Net tangible assets: 18460975.496688742
Owner earnings: 9189636.42384106
Return on net tangible assets (%): 49.77871524443202
Capex to operating income (%): 4.638562320250764
Buffett classification: The Great
Stock price: 0.32450331125827814
P/E ratio: 23.516138196266326
Shares outstanding: 662741837
Book value: 23113813.245033115
P/B ratio: 9.304476000389434
Market cap (USD): 215061920.61589402
Debt to equity: 0.03664254779788514
Current ratio: 3.312389101359805
Quick ratio: 2.67678228782831
Effective tax rate (%): 31.434657468186288
Interest coverage ratio: 88.09711011371499
COGS to revenue (%): 65.45086174381528
SG&A to revenue (%): 12.71267951964637
Free cash flow (dilution-adjusted): 5814548.344370861
Buyback yield (%): 0
Retained earnings: 9762025.165562915
Inventory turnover: 11.116495027406797
Receivables turnover: 12.513448074424026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 55.13646562418827
FCF margin (%): 7.4822704696726055
Revenue growth (%): 68.20131189635869
Rule of 40 score: 75.68358236603129
Financial ratios for VIT.AX — annual report dated 2024-06-30
Total revenue: 82580578.66666667
Gross profit: 22813192.666666668
Operating income: 3244751.3333333335
Net income: 2341585.3333333335
Capital expenditures: 219562.66666666666
Depreciation & amortization: 1094621.3333333333
Net tangible assets: 5031703.333333333
Owner earnings: 3216644.0000000005
Return on net tangible assets (%): 63.92753679834067
Capex to operating income (%): 6.766702409861095
Buffett classification: The Great
Stock price: 0.05333333333333334
P/E ratio: 15.095000298942768
Shares outstanding: 662741837
Book value: 25629538.666666668
P/B ratio: 1.3791208560705528
Market cap (USD): 35346231.30666667
Debt to equity: 0.28669567937079266
Current ratio: 1.325951176509571
Quick ratio: 1.1114418507560935
Effective tax rate (%): 28.79026823140096
Interest coverage ratio: 4.647171715532148
COGS to revenue (%): 72.374627261028
SG&A to revenue (%): 16.407007820434423
Free cash flow (dilution-adjusted): 4140700
Buyback yield (%): 0.09318862421537451
Retained earnings: 8448476.666666666
Inventory turnover: 17.892030628233226
Receivables turnover: 9.017783261387647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.15577746519953
FCF margin (%): 5.01413294367163
Revenue growth (%): 6.266246066087512
Rule of 40 score: 11.280379009759141
Financial ratios for VZUG.SW — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 34191208.79120879
Buffett classification: The Gruesome
Stock price: 130.24175824175822
Shares outstanding: 6411571
Market cap (USD): 835054280.131868
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VZUG.SW — annual report dated 2022-12-31
Total revenue: 691611956.5217391
Gross profit: 213245652.17391303
Operating income: 11183695.652173912
Net income: 8628260.869565217
Capital expenditures: 48368478.26086956
Operating cash flow: 1107608.6956521738
Depreciation & amortization: 34633695.652173914
Net tangible assets: 484285869.5652174
Owner earnings: -5106521.73913043
Return on net tangible assets (%): -1.054443678836834
Capex to operating income (%): 432.49100981630863
Buffett classification: The Gruesome
Stock price: 95.31521739130434
P/E ratio: 70.82774766817838
Shares outstanding: 6411571
Book value: 493277173.91304344
P/B ratio: 1.2388983638487048
Market cap (USD): 611120283.6847826
Debt to equity: 0
Current ratio: 2.0306618600838764
Quick ratio: 1.1175304987227543
Effective tax rate (%): 20.849536344600658
Interest coverage ratio: 108.30526315789473
COGS to revenue (%): 69.16686442982132
R&D to revenue (%): 8.406165181216533
SG&A to revenue (%): 22.28803849859261
Free cash flow (dilution-adjusted): -52865217.391304344
Buyback yield (%): 0
Retained earnings: 347051086.95652175
Inventory turnover: 3.8354350952111202
Receivables turnover: 9.410103967937058
Capitalized R&D asset: 58138043.47826087
ROCI (R&D-adjusted, %): 8.59358926881455
FCF margin (%): -7.6437685746751045
Rule of 40 score: -7.6437685746751045
Financial ratios for VZUG.SW — annual report dated 2023-12-31
Total revenue: 696933333.3333334
Gross profit: 238066666.6666667
Operating income: 19972619.04761905
Net income: 13911904.761904763
Capital expenditures: 68527380.95238096
Operating cash flow: 95776190.47619048
Depreciation & amortization: 37901190.47619048
Net tangible assets: 541439285.7142857
Owner earnings: -16714285.714285716
Return on net tangible assets (%): -3.0870101515141526
Capex to operating income (%): 343.1066340823747
Buffett classification: The Gruesome
Stock price: 74.33333333333333
P/E ratio: 34.257957662159846
Shares outstanding: 6411571
Book value: 552300000
P/B ratio: 0.8629249399480957
Market cap (USD): 476593444.3333333
Debt to equity: 0
Current ratio: 1.826678340744837
Quick ratio: 1.0720951130158294
Effective tax rate (%): 13.934305494181764
Interest coverage ratio: 342.38775510204084
COGS to revenue (%): 65.84082647790319
R&D to revenue (%): 8.533473174997951
SG&A to revenue (%): 23.88046954002569
Free cash flow (dilution-adjusted): 20769047.61904762
Buyback yield (%): 0
Retained earnings: 392147619.04761904
Inventory turnover: 3.9231747905831105
Receivables turnover: 11.83128877751056
Capitalized R&D asset: 98425108.17805383
ROCI (R&D-adjusted, %): 5.909740960054706
Rosenberg metric: 0.4269324010195629
FCF margin (%): 2.9800623138101616
Revenue growth (%): 0.7694165436868041
Rule of 40 score: 3.7494788574969657
Financial ratios for VZUG.SW — annual report dated 2024-12-31
Total revenue: 657461111.111111
Gross profit: 234484444.44444445
Operating income: 28107777.777777776
Net income: 23783333.333333332
Capital expenditures: 59166666.666666664
Operating cash flow: 64408888.88888889
Depreciation & amortization: 33625555.55555555
Net tangible assets: 529983333.3333333
Owner earnings: -1757777.7777777836
Return on net tangible assets (%): -0.3316666142541181
Capex to operating income (%): 210.49926868798673
Buffett classification: The Gruesome
Stock price: 52.56666666666667
P/E ratio: 14.171054613875265
Shares outstanding: 6411571
Book value: 540366666.6666666
P/B ratio: 0.6237152221948061
Market cap (USD): 337034915.56666666
Debt to equity: 0
Current ratio: 1.8256141795891214
Quick ratio: 1.1100375397969364
Effective tax rate (%): 17.584321577083013
Interest coverage ratio: 972.9615384615385
COGS to revenue (%): 64.3348571525143
R&D to revenue (%): 7.469812325190338
SG&A to revenue (%): 25.19912457855556
Free cash flow (dilution-adjusted): 1475555.5555555555
Buyback yield (%): 0
Retained earnings: 390891111.1111111
Inventory turnover: 4.213241397629298
Receivables turnover: 12.040187201139485
Capitalized R&D asset: 108143320.22084197
ROCI (R&D-adjusted, %): 3.206487266915217
Rosenberg metric: -0.06023313382842605
FCF margin (%): 0.22443237031341104
Revenue growth (%): -5.663701294560311
Rule of 40 score: -5.4392689242469
Financial ratios for VZUG.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 529983333.3333333
Buffett classification: The Gruesome
Stock price: 52.56666666666667
Shares outstanding: 6411571
Book value: 540366666.6666666
P/B ratio: 0.6237152221948061
Market cap (USD): 337034915.56666666
Debt to equity: 0
Current ratio: 1.8256141795891214
Quick ratio: 1.1100375397969364
Buyback yield (%): 0
Retained earnings: 390891111.1111111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VZUG.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 589028750
Buffett classification: The Gruesome
Stock price: 79.225
Shares outstanding: 6411571
Book value: 599497500
P/B ratio: 0.8473041380072476
Market cap (USD): 507956712.47499996
Debt to equity: 0
Current ratio: 1.734051083306884
Quick ratio: 0.8552361224796619
Buyback yield (%): 0
Retained earnings: 436300000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WABC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 269000
Buffett classification: The Gruesome
Stock price: 49.37
Shares outstanding: 23002000
Market cap (USD): 1135608740
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WABC — annual report dated 2022-12-31
Total revenue: 264952000
Net income: 122034000
Capital expenditures: 811000
Operating cash flow: 113702000
Depreciation & amortization: 16565000
Net tangible assets: 479854000
Owner earnings: 137788000
Return on net tangible assets (%): 28.71456734756822
Buffett classification: The Gruesome
Stock price: 51.93
P/E ratio: 9.788205418162152
Shares outstanding: 23002000
Book value: 602110000
P/B ratio: 1.983846572885353
Market cap (USD): 1194493860
Debt to equity: 0.02615136769028915
Effective tax rate (%): 26.303965795242494
COGS to revenue (%): 0
SG&A to revenue (%): 17.408813671910384
Free cash flow (dilution-adjusted): 111582000
Buyback yield (%): 0.01825040775010765
Retained earnings: 383094000
Receivables turnover: 4.94701071735315
Capitalized R&D asset: 0
FCF margin (%): 42.114043298408774
Rule of 40 score: 42.114043298408774
Financial ratios for WABC — annual report dated 2023-12-31
Total revenue: 323645000
Net income: 161768000
Capital expenditures: 1161000
Operating cash flow: 158208000
Depreciation & amortization: 11774000
Net tangible assets: 650874000
Owner earnings: 172381000
Return on net tangible assets (%): 26.48454232309172
Buffett classification: The Gruesome
Stock price: 51.5
P/E ratio: 7.3228512437564905
Shares outstanding: 23002000
Book value: 772894000
P/B ratio: 1.5326849477418636
Market cap (USD): 1184603000
Debt to equity: 0.024342277207482527
Effective tax rate (%): 26.99308147432744
COGS to revenue (%): 0
SG&A to revenue (%): 14.791206414435571
Free cash flow (dilution-adjusted): 155691000
Buyback yield (%): 1.1604731711805558
Retained earnings: 490005000
Receivables turnover: 5.93104017006304
Capitalized R&D asset: 0
FCF margin (%): 48.10548594911091
Revenue growth (%): 22.15231438147287
Rule of 40 score: 70.25780033058378
Financial ratios for WABC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.37
Shares outstanding: 23002000
Market cap (USD): 1066602740
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WABC — annual report dated 2024-12-31
Total revenue: 293750000
Net income: 138636000
Capital expenditures: 1744000
Operating cash flow: 141572000
Depreciation & amortization: 10404000
Net tangible assets: 768159000
Owner earnings: 147296000
Return on net tangible assets (%): 19.175196801703816
Buffett classification: The Gruesome
Stock price: 49.64
P/E ratio: 8.236095097954355
Shares outstanding: 23002000
Book value: 889957000
P/B ratio: 1.2830049991179349
Market cap (USD): 1141819280
Debt to equity: 0.020208841550771555
Effective tax rate (%): 26.670510263991666
COGS to revenue (%): 0
SG&A to revenue (%): 17.12068085106383
Free cash flow (dilution-adjusted): 138345000
Buyback yield (%): 0.01839170205638847
Retained earnings: 581555000
Receivables turnover: 6.585436936734968
Capitalized R&D asset: 0
FCF margin (%): 47.09617021276596
Revenue growth (%): -9.23697260887701
Rule of 40 score: 37.85919760388895
Financial ratios for WABC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.64
Shares outstanding: 23002000
Market cap (USD): 1141819280
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WABC — quarterly report dated 2025-03-31
Total revenue: 66416000
Net income: 31037000
Capital expenditures: 199000
Operating cash flow: 42394000
Depreciation & amortization: 2009000
Net tangible assets: 801393000
Owner earnings: 32847000
Return on net tangible assets (%): 4.098738072331553
Buffett classification: The Gruesome
Stock price: 48.32
P/E ratio: 8.952674549730967
Shares outstanding: 23002000
Book value: 923138000
P/B ratio: 1.2039983621083739
Market cap (USD): 1111456640
Debt to equity: 0.021656567057146386
Effective tax rate (%): 25.81801668299912
COGS to revenue (%): 0
SG&A to revenue (%): 18.257648759335098
Free cash flow (dilution-adjusted): 41895000
Buyback yield (%): 1.6397400801888233
Retained earnings: 589062000
Receivables turnover: 1.5767158084656838
Capitalized R&D asset: 0
FCF margin (%): 63.07967959527825
Rule of 40 score: 63.07967959527825
Financial ratios for WABC — quarterly report dated 2025-06-30
Total revenue: 64593000
Net income: 29066000
Capital expenditures: 735000
Operating cash flow: 23517000
Depreciation & amortization: 2212000
Net tangible assets: 800091000
Owner earnings: 30543000
Return on net tangible assets (%): 3.817440766112855
Buffett classification: The Gruesome
Stock price: 46.67
P/E ratio: 17.861060845548476
Shares outstanding: 23002000
Book value: 921783000
P/B ratio: 1.1645944218975617
Market cap (USD): 1073503340
Debt to equity: 0.02210390080962656
Effective tax rate (%): 25.593897194347736
COGS to revenue (%): 0
SG&A to revenue (%): 19.046955552459245
Free cash flow (dilution-adjusted): 22482000
Buyback yield (%): 3.5721360680629086
Retained earnings: 581566000
Receivables turnover: 1.6079510094346667
Capitalized R&D asset: 0
FCF margin (%): 34.80562909293577
Revenue growth (%): -2.744820525174657
Rule of 40 score: 32.06080856776111
Financial ratios for WABC — quarterly report dated 2025-09-30
Total revenue: 63740000
Net income: 28263000
Capital expenditures: 686000
Operating cash flow: 29418000
Depreciation & amortization: 1877000
Net tangible assets: 809973000
Owner earnings: 29454000
Return on net tangible assets (%): 3.636417510213304
Buffett classification: The Gruesome
Stock price: 48.63
P/E ratio: 12.65857071724419
Shares outstanding: 23002000
Book value: 931646000
P/B ratio: 1.200656966272597
Market cap (USD): 1118587260
Debt to equity: 0.0240703013805673
Effective tax rate (%): 25.50606220347918
COGS to revenue (%): 0
SG&A to revenue (%): 19.4336366488861
Free cash flow (dilution-adjusted): 28532000
Buyback yield (%): 2.134746287026369
Retained earnings: 582959000
Receivables turnover: 1.618423725370709
Capitalized R&D asset: 0
FCF margin (%): 44.76310009413241
Revenue growth (%): -1.320576533060858
Rule of 40 score: 43.44252356107155
Financial ratios for WABC — quarterly report dated 2025-12-31
Total revenue: 63309000
Net income: 27807000
Capital expenditures: 626000
Operating cash flow: 26568000
Depreciation & amortization: 1148000
Net tangible assets: 811836000
Owner earnings: 28329000
Return on net tangible assets (%): 3.489497878881942
Buffett classification: The Gruesome
Stock price: 46.98
P/E ratio: 9.301937283189726
Shares outstanding: 23002000
Book value: 933509000
P/B ratio: 1.1576042223481509
Market cap (USD): 1080633960
Debt to equity: 0.023787665678638343
Effective tax rate (%): 26.52009618687736
COGS to revenue (%): 0
SG&A to revenue (%): 18.750888499265507
Free cash flow (dilution-adjusted): 25642000
Buyback yield (%): 2.1592880534681695
Retained earnings: 584633000
Receivables turnover: 1.7044665212826104
Capitalized R&D asset: 0
FCF margin (%): 40.50293007313336
Revenue growth (%): -0.6761844995293379
Rule of 40 score: 39.82674557360403
Financial ratios for WABC — annual report dated 2025-12-31
Total revenue: 258058000
Net income: 116173000
Capital expenditures: 2246000
Operating cash flow: 121897000
Depreciation & amortization: 7246000
Net tangible assets: 811836000
Owner earnings: 121173000
Return on net tangible assets (%): 14.925797821234832
Buffett classification: The Gruesome
Stock price: 46.98
P/E ratio: 9.301937283189726
Shares outstanding: 23002000
Book value: 933509000
P/B ratio: 1.1576042223481509
Market cap (USD): 1080633960
Debt to equity: 0.023787665678638343
Effective tax rate (%): 25.85617094060733
COGS to revenue (%): 0
SG&A to revenue (%): 18.866688883894316
Free cash flow (dilution-adjusted): 118551000
Buyback yield (%): 9.604084624547612
Retained earnings: 584633000
Receivables turnover: 6.947688662735913
Capitalized R&D asset: 0
FCF margin (%): 45.93967247673004
Revenue growth (%): -12.150468085106384
Rule of 40 score: 33.789204391623656
Financial ratios for WHN.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3543307086614173
Shares outstanding: 260146718
Market cap (USD): 92177970.94488189
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WHN.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -8613.970588235294
Operating income: -1408611.0294117646
Net income: -918641.1764705882
Capital expenditures: 6293082.352941176
Operating cash flow: -1482219.1176470588
Depreciation & amortization: 8613.970588235294
Net tangible assets: 24468856.617647056
Owner earnings: -7203109.558823529
Return on net tangible assets (%): -29.437867373126913
Buffett classification: The Gruesome
Stock price: 0.27205882352941174
Shares outstanding: 260146718
Book value: 24468856.61764706
P/B ratio: 2.892460859534982
Market cap (USD): 70775210.04411764
Debt to equity: 0.008977648508480693
Current ratio: 9.215097445220447
Quick ratio: 9.215097445220447
Interest coverage ratio: -99.51745454545454
Free cash flow (dilution-adjusted): -7779402.205882353
Buyback yield (%): 0
Retained earnings: -8470302.205882352
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.721841544876996
Rule of 40 score: 0
Financial ratios for WHN.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -21103.0303030303
Operating income: -1899056.0606060605
Net income: -1996359.0909090908
Capital expenditures: 3686020.4545454546
Operating cash flow: -1285459.0909090908
Depreciation & amortization: 21103.0303030303
Net tangible assets: 23925569.696969695
Owner earnings: -5661276.515151516
Return on net tangible assets (%): -23.662034329191115
Buffett classification: The Gruesome
Stock price: 0.16666666666666666
Shares outstanding: 260146718
Book value: 23925569.696969695
P/B ratio: 1.8121945216972128
Market cap (USD): 43357786.33333333
Debt to equity: 0.00830672725186367
Current ratio: 3.7073019234456943
Quick ratio: 3.7073019234456943
Interest coverage ratio: -85.21157114691685
Free cash flow (dilution-adjusted): -5333695.454545454
Buyback yield (%): 0
Retained earnings: -8889087.121212121
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.721286623805162
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1037037037037037
Shares outstanding: 260146718
Market cap (USD): 26978178.162962962
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 260146718
Market cap (USD): 18192078.181818184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WHN.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -33677.62237762238
Operating income: -1441374.1258741259
Net income: -1801727.972027972
Capital expenditures: 3743360.839160839
Operating cash flow: -1149362.937062937
Depreciation & amortization: 33677.62237762238
Net tangible assets: 25973973.42657343
Owner earnings: -5511411.188811189
Return on net tangible assets (%): -21.21897600454376
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 260146718
Book value: 25973973.426573426
P/B ratio: 0.7003964269558485
Market cap (USD): 18192078.181818184
Debt to equity: 0.0026626169251403944
Current ratio: 2.6930593884216947
Quick ratio: 2.6930593884216947
Interest coverage ratio: -19.466623222077406
Free cash flow (dilution-adjusted): -5166849.6503496505
Buyback yield (%): 0
Retained earnings: -9398981.11888112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.271998780861551
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -9663.636363636364
Operating income: -234253.14685314687
Net income: -73740.55944055945
Capital expenditures: 1067727.972027972
Operating cash flow: -163165.73426573427
Depreciation & amortization: 9663.636363636364
Net tangible assets: 25938325.174825177
Owner earnings: -1131804.895104895
Return on net tangible assets (%): -4.363446319207167
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 260146718
Book value: 25938325.174825177
P/B ratio: 0.9819026202688169
Market cap (USD): 25468909.454545457
Debt to equity: 0.0019135224074428299
Current ratio: 1.2256974854563931
Quick ratio: 1.2256974854563931
Interest coverage ratio: -44.421429518631484
Free cash flow (dilution-adjusted): -1259594.4055944057
Buyback yield (%): 0
Retained earnings: -9472721.678321678
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8580783555240903
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -10072.262773722627
Operating income: -344437.95620437956
Net income: -121429.19708029197
Capital expenditures: 830477.3722627737
Operating cash flow: -346765.6934306569
Depreciation & amortization: 10072.262773722627
Net tangible assets: 29876875.912408758
Owner earnings: -941834.306569343
Return on net tangible assets (%): -3.152385508212293
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
Shares outstanding: 260146718
Book value: 29876876.642335765
P/B ratio: 0.8897963620573107
Market cap (USD): 26584336.145985402
Debt to equity: 0.004990383769925236
Current ratio: 4.631001838594844
Quick ratio: 4.631001838594844
Interest coverage ratio: -447.7039848197344
Free cash flow (dilution-adjusted): -1202661.313868613
Buyback yield (%): 0
Retained earnings: -9685741.605839415
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0980084205620764
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -9984.892086330936
Operating income: -423105.75539568346
Net income: -255766.18705035973
Capital expenditures: 1369731.654676259
Operating cash flow: -539220.1438848921
Depreciation & amortization: 9984.892086330936
Net tangible assets: 31410886.330935255
Owner earnings: -1615512.9496402878
Return on net tangible assets (%): -5.14316257306384
Buffett classification: The Gruesome
Stock price: 0.14388489208633096
Shares outstanding: 260146718
Book value: 31410886.330935255
P/B ratio: 1.191662726472598
Market cap (USD): 37431182.44604317
Debt to equity: 0.004144807789225437
Current ratio: 6.265571039663137
Quick ratio: 6.265571039663137
Interest coverage ratio: -91.9220068771491
Free cash flow (dilution-adjusted): -1927150.3597122303
Buyback yield (%): 0
Retained earnings: -9703065.4676259
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.287407593523868
Rule of 40 score: 0
Financial ratios for WHN.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -40621.89781021897
Operating income: -1644470.802919708
Net income: -1852468.613138686
Capital expenditures: 4407486.131386861
Operating cash flow: -1657557.6642335765
Depreciation & amortization: 40621.89781021897
Net tangible assets: 30781678.10218978
Owner earnings: -6219332.846715328
Return on net tangible assets (%): -20.20465819331952
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
Shares outstanding: 260146718
Book value: 30781678.10218978
P/B ratio: 1.665594415238812
Market cap (USD): 51269791.138686135
Debt to equity: 0.0055810761824166945
Current ratio: 2.9578729378532653
Quick ratio: 2.9578729378532653
Interest coverage ratio: -116.78027161517728
Free cash flow (dilution-adjusted): -6155627.737226278
Buyback yield (%): 0
Retained earnings: -11240126.277372262
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.993234639973139
Rule of 40 score: 0
Financial ratios for WHN.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -10332.116788321167
Operating income: -626238.6861313868
Net income: -1395410.218978102
Capital expenditures: 1072791.2408759124
Operating cash flow: -593388.3211678831
Depreciation & amortization: 10332.116788321167
Net tangible assets: 30781678.10218978
Owner earnings: -2457869.343065693
Return on net tangible assets (%): -7.984845189095921
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
Shares outstanding: 260146718
Book value: 30781678.10218978
P/B ratio: 1.665594415238812
Market cap (USD): 51269791.138686135
Debt to equity: 0.0055810761824166945
Current ratio: 2.9578729378532653
Quick ratio: 2.9578729378532653
Interest coverage ratio: -157.42146788990826
Free cash flow (dilution-adjusted): -1682923.3576642335
Buyback yield (%): 0
Retained earnings: -11240126.277372262
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9014972445425542
Rule of 40 score: 0
Financial ratios for WLDN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.2
Shares outstanding: 15110606
Market cap (USD): 531893331.20000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WLDN — annual report dated 2022-12-31
Total revenue: 429138000
Gross profit: 143579000
Operating income: -7063000
Net income: -8448000
Capital expenditures: 9527000
Operating cash flow: 9433000
Depreciation & amortization: 17489000
Net tangible assets: 9892000
Owner earnings: -486000
Return on net tangible assets (%): -4.913061059441973
Buffett classification: The Gruesome
Stock price: 17.85
Shares outstanding: 15110606
Book value: 181502000
P/B ratio: 1.4860680163303985
Market cap (USD): 269724317.1
Debt to equity: 0.6797996716289628
Current ratio: 1.368053535059645
Quick ratio: 1.368053535059645
Interest coverage ratio: -1.3256381381381381
COGS to revenue (%): 66.54246419566667
SG&A to revenue (%): 31.028014298430804
Free cash flow (dilution-adjusted): -8542000
Buyback yield (%): 0
Retained earnings: 3651000
Receivables turnover: 2.8988955314621543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5001327410134335
FCF margin (%): -1.9905018898349713
Rule of 40 score: -1.9905018898349713